TransMedics (TMDX) Total Non-Current Liabilities (2022 - 2026)

TransMedics (TMDX) recorded quarterly Total Non-Current Liabilities of $936.8 million in Q1 2026, up 66.47% quarter-over-quarter from $562.8 million in Q3 2023.

TransMedics (TMDX) Total Non-Current Liabilities (2022 - 2026) Analysis & Trends

TransMedics' Total Non-Current Liabilities history runs 3 years deep, the most recent figure standing at $936.8 million for Q1 2026.

  • In Q1 2026, Total Non-Current Liabilities changed N/A year-over-year to $936.8 million; the TTM figure through Mar 2026 stood at $936.8 million (changed N/A YoY), while the FY2022 annual figure was $89.8 million, changed N/A from the prior year.
  • Total Non-Current Liabilities was $936.8 million for Q1 2026 at TransMedics, up from $562.8 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $936.8 million in Q1 2026 to a low of $89.8 million in Q4 2022.
  • Historically, Total Non-Current Liabilities has averaged $445.8 million across 3 years, with a median of $545.1 million in 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 20.94 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 40.52 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 15.78 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 2.44 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 9.85 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 3.53 Bn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 24.21 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 3.47 Bn
10 TransMedics 2.72 Bn 2.26 Bn 101.16 Mn 936.83 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 936.83 Mn
Sep 30, 2023 562.77 Mn
Jun 30, 2023 545.15 Mn
Mar 31, 2023 94.46 Mn
Dec 31, 2022 89.77 Mn